Disease: Heparin induced thrombocytopenia
- 2023 ISTH update of the 2022 ISTH guidelines for antithrombotic treatment in COVID-19
- A career in solving clinical-pathological conundrums: Heyde syndrome, anti-platelet factor 4 disorders, and microvascular limb ischemic necrosis
- A Case Report of Pulmonary Embolectomy Under Cardiopulmonary Bypass in a Patient with Intracranial Hemorrhage and History of Heparin-Induced Thrombocytopenia
- A retrospective analysis of the frequency of heparin-induced thrombocytopenia in the intensive care unit at a tertiary care center in Riyadh, Saudi Arabia
- A woman with eptifibatide (integrilin)-induced thrombocytopenia following treatment of a clot in her coronary artery: A case report and literature review
- Accuracy of Diagnosing Heparin-Induced Thrombocytopenia
- Acute coronary thrombosis due to heparin-induced thrombocytopenia following improved COVID-19 pneumonia: A case report
- An Updated Comprehensive Pharmacovigilance Study of Drug-Induced Thrombocytopenia Based on FDA Adverse Event Reporting System Data
- Analysis of hospital length of stay and cost savings with an in-house heparin-induced thrombocytopenia antibody assay at a midsized institution
- Anti-PF4 antibodies and their relationship with COVID infection
- Anti-PF4 immunothrombosis without proximate heparin or adenovirus vector vaccine exposure
- Anticoagulation practices for continuous renal replacement therapy: a survey of physicians from the United States
- Argatroban
- Association between time of heparin exposure and platelets decline in patients with heparin induced thrombocytopenia
- Autoimmune Heparin-Induced Thrombocytopenia
- Autoimmune Heparin-Induced Thrombocytopenia: A Diagnostic and Management Challenge After Transcatheter Aortic Valve Replacement
- Availability of medical and endovascular therapies for venous thromboembolism: a global survey for World Thrombosis Day
- Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?
- Between a rock and a hard place: anticoagulation management for ECMO
- Biophysical studies do not reveal direct interactions between human PF4 and Ad26.COV2.S vaccine
- Bivalirudin anticoagulation for cardiopulmonary bypass during cardiac surgery
- Bivalirudin as a substitute for heparin in neurointervention for patients with heparin-induced thrombocytopenia
- Bolus-only bivalirudin for carotid endarterectomy in a patient with heparin-induced thrombocytopenia
- Cancer-associated thrombosis and bleeding
- Cangrelor for cardiopulmonary bypass in delayed-onset heparin-induced thrombocytopenia: a case report
- Challenges in the Monitoring of Therapeutic Plasma Exchange during Acute Heparin-Induced Thrombocytopenia in Adults under ECMO
- Characterization of complexes of PF4 and heparins by size-exclusion chromatography coupled with multi-angle light scattering detector
- Characterization of the Benefits and Risks of Therapeutic Anticoagulation in Patients Admitted with Severe COVID-19 (CRITAC)
- Complex management of pulmonary embolism in APLA syndrome: a case study of ECMO and bivalirudin utilization
- COVID-19 vaccine-induced immune thrombotic thrombocytopenia: a review
- COVID-19 vaccine-induced immune thrombotic thrombocytopenia: pathophysiology and diagnosis
- Critical Analysis of Thrombocytopenia Associated With Glycoprotein IIb/IIIa Inhibitors and Potential Role of Zalunfiban, a Novel Small Molecule Glycoprotein Inhibitor, in Understanding the Mechanism(s)
- Dabigatran Etexilate Related Unilateral Adrenal Hemorrhage
- Decision-Making Error in Platelet Transfusion Caused by EDTA-Dependent Pseudothrombocytopenia: a Case Report and Literature Review
- Delayed-onset eptifibatide-induced thrombocytopenia
- Diagnosis and management of heparin-induced thrombocytopenia: Third edition
- Diagnostic value of antibody-induced procoagulant platelets in heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology
- Distinctions between survivors and non-survivors with SARS-CoV-2 vaccine-induced thrombotic thrombocytopenia: A systematic review and meta-analysis
- Effectiveness and safety of therapeutic plasma exchange to modify the functionality of heparin-induced thrombocytopenia antibodies and correct profound thrombocytopenia: A case report and literature review
- Effectiveness, Safety, and Costs of Thromboprophylaxis with Enoxaparin or Unfractionated Heparin Among Medical Inpatients With Chronic Obstructive Pulmonary Disease or Heart Failure
- Evaluating the Use of Unfractionated Heparin with Intra-Aortic Balloon Counterpulsation
- Evaluation of Bivalirudin During Adult Extracorporeal Membrane Oxygenation: A Retrospective Characterization of Dosing, Efficacy and Bleeding
- Extensive arm skin necrosis following administration of unfractionated heparin
- Fc<em>γ</em>RIIa - dependent platelet activation identified in COVID-19 vaccine-induced immune thrombotic thrombocytopenia-, heparin-induced thrombocytopenia, streptokinase- and anisoylated plasminogen-streptokinase activator complex-induced p
- FcgammaRIIa - dependent platelet activation identified in COVID-19 vaccine-induced immune thrombotic thrombocytopenia-, heparin-induced thrombocytopenia, streptokinase- and anisoylated plasminogen-streptokinase activator complex-induced platelet activatio
- Heparin-activated procoagulant platelet assay: a flow cytometry-based functional test for heparin-induced thrombocytopenia
- Heparin-induced thrombocytopaenia complicating cardiogenic shock requiring durable mechanical circulatory support: a case report
- Heparin-induced thrombocytopenia (and autoimmune heparin-induced thrombocytopenia): an illustrious review
- Heparin-Induced Thrombocytopenia in Hemodialysis Patients- The First Study from India
- Heparin-induced thrombocytopenia in newborns: experience at a pediatric hospital and a literature review
- HEPARIN-INDUCED THROMBOCYTOPENIA SYNDROME AMONG HEMODIALYSIS PATIENTS AND DISEASE MANAGEMENT STRATEGY
- Heparin-induced Thrombocytopenia with Anaphylactoid Reaction during Hemodialysis
- Heparin-induced Thrombocytopenia with Thrombosis in COVID-19 versus Vaccine-induced Immune Thrombocytopenia and Thrombosis in the United Kingdom
- Heparin-Induced Thrombocytopenia: A Case Report Four Years After the Initiation of Maintenance Hemodialysis
- High-Dose Immunoglobulin Therapy for Multiple Thromboembolism in Persisting Heparin-Induced Thrombocytopenia
- How to manage splanchnic vein thrombosis in patients with liver disease
- Immune-stealth VP28-conjugated heparin nanoparticles for enhanced and reversible anticoagulation
- Immunologic Effects of Heparin Associated With Hemodialysis: Focus on Heparin-Induced Thrombocytopenia
- Impact of Embedding a Venous Thromboembolism Risk Assessment Model in the Electronic Health Record Versus Usual Care: A Cluster-Randomized Trial
- Improving methods of clinical practice guidelines: From guidelines to pathways to fast-and-frugal trees and decision analysis to develop individualised patient care
- In vitro Hemostatic Functions of Cold-Stored Platelets
- Intraoperative argatroban vessel irrigation during microsurgical anastomosis in heparin-induced thrombocytopenia patients: About two cases
- Intraoperative Bivalirudin Use in Patient Undergoing Femoral Endarterectomy with Heparin-Induced Thrombocytopenia: Case Report and Review of the Literature
- Key considerations in navigating ticagrelor's reported effect on heparin-induced thrombocytopenia functional assays in a landscape of limited data
- Laboratory approach for vaccine-induced thrombotic thrombocytopenia diagnosis in the Netherlands
- Limb Ischemic Necrosis Secondary to Microvascular Thrombosis: A Brief Historical Review
- Management of cancer-associated thromboembolism in vulnerable population
- Management of heparin-induced thrombocytopenia during extracorporeal membrane oxygenation support: a case of neutropenia caused by argatroban anticoagulation
- Molecular architecture and platelet-activating properties of small immune complexes assembled on heparin and platelet factor 4
- Multiple thromboses, including intracardiac thrombi, accompanied by HIT during ECMO successfully treated with NOACs: A case report
- New recommendations on cerebral venous and dural sinus thrombosis from the German consensus-based (S2k) guideline
- Online hemodiafiltration without calcium replacement using citrate as an anticoagulant and dialysis fluid with 3.5 mEq of post dilutional calcium in patients with heparin-induced thrombocytopenia: Report of 2 cases
- Outcomes of heparin-induced thrombocytopenia type II in aneurysmal subarachnoid hemorrhage patients: A US nationwide analysis
- Performance evaluation of heparin-induced platelet aggregation vs serotonin release assay
- Perioperative Plasma Exchange and Intravenous Immunoglobulin Use for Refractory Heparin-Induced Thrombocytopenia in a Liver Transplant Recipient
- PF4 activates the c-Mpl-Jak2 pathway in platelets
- Platelet Factor 4 Antibodies and Severe AKI
- Platelet factor 4(PF4) and its multiple roles in diseases
- Proteomic profiling for biomarker discovery in heparin-induced thrombocytopenia
- Quality improvement approaches to heparin-induced thrombocytopenia: a scoping review
- Recurrent Venous Thromboembolism in Patients on Anticoagulation: An Update Based on the Revised AWMF S2k Guideline
- Repeated occurrence of severe hypotension associated with azithromycin infusion in a patient with fulminant myocarditis: a case report
- Results of an international survey of opinions on the definitions and treatments for heparin-induced thrombocytopenia: communication from the ISTH SSC Subcommittee on Platelet Immunology
- Structured benefit-risk assessment for enoxaparin, in the context of its label extension, for the extended treatment of deep vein thrombosis and pulmonary embolism, and prevention of its recurrence in patients with active cancer
- Successful Treatment With the Oral Factor Xa Inhibitor Edoxaban in Heparin-Induced Thrombocytopenia With Thrombosis
- Temporal changes in biomarkers of neutrophil extracellular traps and NET-promoting autoantibodies following adenovirus-vectored, mRNA, and recombinant protein COVID-19 vaccination
- The Binding of the SARS-CoV-2 Spike Protein to Platelet Factor 4: A Proposed Mechanism for the Generation of Pathogenic Antibodies
- The efficacy and safety of direct oral anticoagulants in the treatment of the acute phase of heparin-induced thrombocytopenia: A systematic review
- Therapeutic strategies in FcgammaIIA receptor-dependent thrombosis and thromboinflammation as seen in heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombocytopenia and thrombosis (VITT)
- Thromboprophylaxis in hospitalized trauma patients: a systematic review and meta-analysis of implementation strategies
- Thrombosis
- Thrombosis and Bleeding in Patients with Vaccine-Induced Immune Thrombotic Thrombocytopenia: A Systematic Review of Published Cases
- Thrombotic anti-PF4 immune disorders: HIT, VITT, and beyond
- Treating Heparin-Induced Thrombocytopenia in Patients Undergoing HeartMate 3 Left Ventricular Assist Device Implantation
- Type II Heparin-Induced Thrombocytopenia Manifesting As Cardiac Arrest Following Intravenous Heparin Bolus During an Elective Procedure: A Case Report and Literature Review
- Unlocking the potential of fondaparinux: guideline for optimal usage and clinical suggestions (2023)
- Vaccine-Induced Immune Thrombotic Thrombocytopenia: Clinicopathologic Features and New Perspectives on Anti-PF4 Antibody-Mediated Disorders
- Veno-venous Extracorporeal Membrane Oxygenation: Anesthetic Considerations in Clinical Practice
- Where have all the platelets gone? HIT, DIC, or something else?
- Zosyn-Induced Rapid Thrombocytopenia in a Patient With End-Stage Renal Disease and HIV: A Case Report